美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=TYLENOL"
符合检索条件的记录共15
2 页 当前第 1 页  下一页 最后一页 返回检索页
1药品名称TYLENOL
申请号017756产品号001
活性成分ACETAMINOPHEN市场状态停止上市
剂型或给药途径SUPPOSITORY;RECTAL规格650MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION
2药品名称TYLENOL
申请号017756产品号002
活性成分ACETAMINOPHEN市场状态停止上市
剂型或给药途径SUPPOSITORY;RECTAL规格120MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION
3药品名称TYLENOL
申请号019872产品号001
活性成分ACETAMINOPHEN市场状态非处方药
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格650MG
治疗等效代码参比药物
批准日期1994/06/08申请机构JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION
4药品名称TYLENOL
申请号019872产品号002
活性成分ACETAMINOPHEN市场状态非处方药
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格650MG
治疗等效代码参比药物
批准日期2001/01/11申请机构JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIVISION
5药品名称TYLENOL W/ CODEINE NO. 1
申请号085055产品号001
活性成分ACETAMINOPHEN; CODEINE PHOSPHATE市场状态停止上市
剂型或给药途径TABLET;ORAL规格300MG;7.5MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构JANSSEN PHARMACEUTICALS INC
6药品名称TYLENOL W/ CODEINE NO. 2
申请号085055产品号002
活性成分ACETAMINOPHEN; CODEINE PHOSPHATE市场状态停止上市
剂型或给药途径TABLET;ORAL规格300MG;15MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构JANSSEN PHARMACEUTICALS INC
7药品名称TYLENOL W/ CODEINE NO. 3
申请号085055产品号003
活性成分ACETAMINOPHEN; CODEINE PHOSPHATE市场状态处方药
剂型或给药途径TABLET;ORAL规格300MG;30MG
治疗等效代码AA参比药物
批准日期Approved Prior to Jan 1, 1982申请机构JANSSEN PHARMACEUTICALS INC
8药品名称TYLENOL W/ CODEINE NO. 4
申请号085055产品号004
活性成分ACETAMINOPHEN; CODEINE PHOSPHATE市场状态处方药
剂型或给药途径TABLET;ORAL规格300MG;60MG
治疗等效代码AA参比药物
批准日期Approved Prior to Jan 1, 1982申请机构JANSSEN PHARMACEUTICALS INC
9药品名称TYLENOL W/ CODEINE
申请号085056产品号001
活性成分ACETAMINOPHEN; CODEINE PHOSPHATE市场状态停止上市
剂型或给药途径TABLET;ORAL规格325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ORTHO MCNEIL PHARMACEUTICAL INC
10药品名称TYLENOL W/ CODEINE
申请号085056产品号002
活性成分ACETAMINOPHEN; CODEINE PHOSPHATE市场状态停止上市
剂型或给药途径TABLET;ORAL规格325MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ORTHO MCNEIL PHARMACEUTICAL INC